Europe backs nuclear medicine for cancer that killed Steve Jobs

LONDON (Reuters) - A nuclear medicine targeting the type of cancer that killed Steve Jobs won a green light from EU regulators on Friday, boosting prospects for its developer Advanced Accelerator Applications.